Summit Rock Advisors, LP Diversified Active

Location: New York, NY

CIK: 0001540951 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Oct 26, 2021

Total Value: $169M (100.0% shares, 0.0% debt)

Holdings (5)

IWN ISHARES TR 39.4%

Value $66.34M Shares 414,052 Share Price $160.23 Est. Cost/Share $164.95 Unrealized @ Report Date -2.9%

IUSV ISHARES TR 31.1%

Value $52.47M Shares 740,195 Share Price $70.88 Est. Cost/Share $54.86 Unrealized @ Report Date +29.2%

VTV VANGUARD INDEX FDS 28.0%

Value $47.12M Shares 348,077 Share Price $135.37 Est. Cost/Share $132.45 Unrealized @ Report Date +2.2%

CLOV CLOVER HEALTH INVESTMENTS CO 0.9%

Value $1.556M Shares 210,639 Share Price $7.39 Est. Cost/Share $8.56 Unrealized @ Report Date -13.6%

PHAT PHATHOM PHARMACEUTICALS INC 0.6%

Value $1.094M Shares 34,100 Share Price $32.08 Est. Cost/Share $38.42 Unrealized @ Report Date -16.5%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
IWN	ISHARES TR	414,052	$66.34M	39.4%	$160.23	$164.95	-2.9%	RUS 2000 VAL ETF	464287630
IUSV	ISHARES TR	740,195	$52.47M	31.1%	$70.88	$54.86	+29.2%	CORE S&P US VLU	464287663
VTV	VANGUARD INDEX FDS	348,077	$47.12M	28.0%	$135.37	$132.45	+2.2%	VALUE ETF	922908744
CLOV	CLOVER HEALTH INVESTMENTS CO	210,639	$1.556M	0.9%	$7.39	$8.56	-13.6%	COM CL A	18914F103
PHAT	PHATHOM PHARMACEUTICALS INC	34,100	$1.094M	0.6%	$32.08	$38.42	-16.5%	COM	71722W107